SUNHO (CHINA) BIOPHARMACEUTICAL CO.

sunho-china-biopharmaceutical-co-logo

SunHo (China) BioPharmaceutical Co. is a biopharmaceutical company that manufactures biological products.

#SimilarOrganizations #Website #More

SUNHO (CHINA) BIOPHARMACEUTICAL CO.

Social Links:

Industry:
Biotechnology Manufacturing Pharmaceutical

Founded:
2018-01-01

Address:
Nanjing, Jiangsu, China

Country:
China

Website Url:
http://www.sunho-bio.com

Total Employee:
101+

Status:
Active

Contact:
+86 025 85666008

Email Addresses:
[email protected]


Similar Organizations

akesis-pharmaceuticals-logo

Akesis Pharmaceuticals

Akesis Pharmaceuticals is a pharmaceutical company that manufactures general medicines.

awamedica-logo

Awamedica

Awamedica is a pharmaceutical company that manufactures medical products.

azkka-logo

Azkka

Azkka is a pharmaceutical company that manufactures medical products.

celestial-biolabs-logo

Celestial Biolabs

Celestial Biolabs is an agency that produces biotechnological products that have implications in the Pharmaceutical sector.

covalent-laboratories-logo

Covalent Laboratories

Covalent Laboratories is a pharmaceutical company that manufactures cephalosporins.

riyadh-pharma-logo

Riyadh Pharma

Riyadh Pharma is a pharmaceutical company that manufactures licensed and generic medicinal products.

silco-pharmaceuticals-logo

Silco Pharmaceuticals

Silco Pharmaceuticals manufactures a wide range of tablets.

not_available_image

Syncom Formulations

Syncom Formulations is a pharmaceutical company that manufactures formulation products.

tecnovax-logo

Tecnovax

Tecnovax is a biopharmaceutical company that manufactures biological products for animal health.

valaji-pharma-chem-logo

Valaji Pharma Chem

Valaji Pharma Chem is a pharmaceutical company that manufactures inorganic salts.

Stock Details


Company's stock symbol is HKG:2898

Official Site Inspections

http://www.sunho-bio.com

  • Host name: 222.73.219.195
  • IP address: 222.73.219.195
  • Location: China
  • Latitude: 31.0449
  • Longitude: 121.4012
  • Timezone: Asia/Shanghai

Loading ...

More informations about "SunHo (China) BioPharmaceutical Co."

SUNHO (CHINA)BIOPHARMACEUTICAL Co.,Ltd.

SunHo is a biopharmaceutical company committed to the discovery, development and commercialization of first-in-class/best-in-class biologics that regulate immune microenvironment by directly modulating both the innate and adaptive …See details»

SUNHO (CHINA)BIOPHARMACEUTICAL Co.,Ltd.

About SunHo Company Profile Corporate Culture Development Strategy Manufacturing Base Team Team Overview R&D Platform Armed ImmunoCytokine Platform, AIC™ ADCC …See details»

SUNHO (CHINA)BIOPHARMACEUTICAL Co.,Ltd.

SunHo is a biopharmaceutical company committed to the discovery, development and commercialization of first-in-class/best-in-class biologics that regulate immune microenvironment by directly modulating both the innate and adaptive …See details»

盛禾(中国)生物制药有限公司 - SUNHO …

盛禾(中国)生物制药有限公司. 我们是一家生物制药公司,致力于发现、开发和商业化同类首创/同类最佳的生物制剂,See details»

SunHo (China) BioPharmaceutical Co. - Crunchbase

SunHo (China) BioPharmaceutical Co. is a biopharmaceutical company that manufactures biological products. Nanjing, Jiangsu, China; 101-250; Public; www.sunho-bio.com ...See details»

Sunho Biologics Company Description - Stock Analysis

Nov 15, 2024 Company profile for Sunho Biologics, Inc. (HKG: 2898) with a description, list of executives, contact details and other key facts.See details»

Sunho Biologics, Inc. - Drug pipelines, Patents, Clinical trials

Last update 01 Nov 2024. Sunho Biologics, Inc. Public Company |See details»

SunHo (China) BioPharmaceutical Co. - Funding, Financials, …

May 24, 2024 Organization. SunHo (China) BioPharmaceutical Co. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... IPO & Stock Price. Edit IPO & …See details»

Organization | SUNHO(China)BioPharmaceutical CO., Ltd. - CDEK

Organization Overview. First Clinical Trial. 2021 NCT04934514. First Marketed Drug. None First NDA Approval. None ... SUNHO(China)BioPharmaceutical CO., Ltd. Active Ingredients. …See details»

北京星昊医药股份有限公司 - sunho.com.cn

A brief Introduction of Beijing Sunho. Beijing Sunho Pharmaceutical Co., Ltd. was founded in 2000. By 2023, Sunho has assets of nearly 1.8 billion yuan and over 800 employees. ... and …See details»

Organization: Sunho Biologics - Cbonds.com

Sunho Biologics Inc is a China-based company mainly engaged in the research, development and production of biotechnology. The Company is primarily engaged in the discovery, development …See details»

Sunho (China) Biopharmaceutical Co., Ltd. - Drug pipelines, …

Nov 4, 2024 NANJING, China, July 21, 2023 /PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. (" SunHo"), a clinical-stage leading biopharmaceutical company in immunocytokines with …See details»

Sunho (China) Biopharmaceutical Co., Ltd. (盛禾(中国)生物制药 …

了解Sunho (China) Biopharmaceutical Co., Ltd. (盛禾(中国)生物制药有限公司)公司的药物管线,治疗领域,技术平台,以及它的19项临床试验, 105篇新闻,疾病领域:肿瘤,免疫系统疾 …See details»

Sunho Biopharmaceutical - Products, Competitors, Financials, …

Sunho Biopharmaceutical is a biopharmaceutical company focused on the discovery, development, and commercialization of biologics that regulate the immune microenvironment. …See details»

SUNHO (CHINA)BIOPHARMACEUTICAL Co.,Ltd. - sunho-bio.com

Our commitment to innovation and patients starts with our experienced leadership team. With industry insights, they are empowered to make novel therapeutic biologics in areas where …See details»

Home - SUNHO (CHINA)BIOPHARMACEUTICAL Co.,Ltd.

The Most Reliable Plumbing Services in San FranciscoWe. We can supply you with top of the line plumbing, drain cleaning, sprinkler work, water heaters and much, much more!See details»

SunHo Bio Starts China Trials of Immunocytokine for Solid Tumor …

Jul 26, 2023 Nanjing SunHo BioPharma has started China Phase I/II trials of a B7H3-IL10 immunocytokine as a potential first-in-class therapy to treat locally advanced or metastatic …See details»

SUNHO (CHINA)BIOPHARMACEUTICAL Co.,Ltd.

SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 . SunHo BioPharmaceutical Co., Ltd. (“SunHo”), a …See details»

Despite a nearly 70% drop in valuation since its IPO, SUNHO BIO …

Oct 18, 2024 After the listing of SUNHO BIO-B, the stock price has dropped significantly, nearly 70% below the issue price, facing the cornerstone unlocking date. The company has only …See details»

linkstock.net © 2022. All rights reserved